ARGOBIO
Paris · Founded 2021
About ARGOBIO
Argobio is a start-up studio devoted to developing unique therapeutic solutions, with the purpose of nurturing and launching revolutionary biotech firms. It sources cutting-edge early-stage projects from leading European academic research institutes in order to cultivate and nurture these projects before launching companies. The main focus is on rare diseases, neurological issues, oncology, and immunology. Additionally, the studio is looking to create promising platform technologies for therapeutic products.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $60.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2021)
- Website: argobiostudio.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/argobio-21789 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.